Floatz logo

Cyclophosphamide

T-Cell Large Granular Lymphocyte Leukemia

Case Comprehensive Cancer CenterSmall moleculePhase 2Dormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the T-Cell Large Granular Lymphocyte Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 2BBB
Cyclosporin A
Case Comprehensive Cancer Center
Phase 2BB
BUSULFANUM
Ohio State University Comprehensive Cancer Center
Phase 2BB
Rituximab
Northwestern University
Phase 2B
TACROLIMUS
University of Medicine and Dentistry of New Jersey
Phase 2B

View all 47 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
mycosis fungoidesActive
BBB
Indicative · Phase 4
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →